South African company Afrigen Biologics has used the available sequence from Moderna's covid-19 mRNA vaccine to produce its own version of the vaccine, which by before the end of 2022 can be tested in humans. "We did not copy Moderna, we developed our own processes because Moderna did not give us any technology," said Petro Terblanche, CEO of...
